New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For IN;HON;NXY;CEO;MCD;CLDX;ZGNX From The Last 14 Days
Check below for free stories on IN;HON;NXY;CEO;MCD;CLDX;ZGNX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
April 7, 2014
16:02 EDTCLDXCelldex says CDX-014 to enter clinical development
Celldex Therapeutics reported results of preclinical studies evaluating the anti-tumor activity of CDX-014 against a variety of cell lines. Based on the results, CDX-014 will enter clinical development. CDX-014 is an antibody drug conjugate that targets the protein TIM-1. "The data presented today confirm that CDX-014 effectively targets the tumor marker TIM-1 in vitro and elicits significant anti-tumor activity in key models. We are currently completing manufacturing and IND-enabling studies and anticipate that CDX-014 will enter Phase 1 clinical studies in renal cell carcinoma and potentially other TIM-1 expressing tumors in 2015," said Tibor Keler, senior VP and Chief Scientific Officer of Celldex.
09:39 EDTHONHoneywell announces CFO to retire, Vice Chairmen promoted
Subscribe for More Information
06:31 EDTCEOCNOOC mulls sale of $3.1B Bridas stake, Bloomberg says
Subscribe for More Information
April 4, 2014
09:50 EDTCLDXCelldex management to meet with Guggenheim
Meetings to be held in New York on April 10-11 hosted by Guggenheim.
06:54 EDTMCDMcDonald's ceases work in Crimea, Reuters says
Subscribe for More Information
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use